Clinical trials
Phase 1/2 Overweight trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 3 |
| Recruiting | 2 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2 |
| University of California, San Francisco | 2 |
| Alnylam Pharmaceuticals | 1 |
| Columbia University | 1 |
| Forma Therapeutics, Inc. | 1 |
| Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Metsera, a wholly owned subsidiary of Pfizer | 1 |
| Ohio State University | 1 |
| Pennington Biomedical Research Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Overweight | 19 |
| Obesity | 16 |
| Prediabetic State | 2 |
| Diabetes Mellitus, Type 2 | 1 |
| Dwarfism | 1 |
| Dwarfism, Pituitary | 1 |
| Glucose Intolerance | 1 |
| Hypertension | 1 |
| Insulin Resistance | 1 |
| Non-alcoholic Fatty Liver Disease | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.